Delisting risk
Biodexa Pharmaceuticals (ADR) (BDRX)
Advancing licensed therapies for familial adenomatous polyposis, treatment-resistant GIST, and type 1 diabetes.
$0.7700
Pre-market−0.01 (−1.90%)
At close$0.7849(+0.53%)
Something off on this page? Send us feedback.
Next report
Sep 11, 2026
in 8 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q1 FY26
EPSReportedEstimate
Apr '23Sep '23Apr '24Sep '24Apr '25Sep '25Mar '26Sep '26
Reported−$36,466.51−$2,773.25−$3.54−$0.33−$0.01$0.00$0.00Pending
Estimate——−$3.54−$0.22−$0.01$0.00−$0.01—
Surprise——−0.1%−49.8%−5.2%—+91.4%—
RevenueReportedEstimate
Apr '23Sep '23Apr '24Sep '24Apr '25Sep '25Mar '26Sep '26
Reported$283.9K$377.4K$106.0K————Pending
Estimate——$105.8K$16.6K$16.6K———
Surprise——+0.2%—————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | — | — | — |
| Mar 2026 | −$0.01 | $0.00 | +91.4% |
| Sep 2025 | $0.00 | $0.00 | — |
| Apr 2025 | −$0.01 | −$0.01 | −5.2% |
| Sep 2024 | −$0.22 | −$0.33 | −49.8% |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | |||
| Apr 2024 | |||
| Sep 2023 | |||
| Apr 2023 | |||
| Sep 2022 | |||
| Apr 2022 | |||
| Sep 2021 | |||
| Apr 2021 | |||
| Sep 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Apr 2019 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Jun 2014 | |||
| Dec 2013 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | — | — | — | — | — | — | — |
| Mar 27, 2026 | −$0.01 | $0.00 | +91.4% | — | — | — | −6.4% |
| Sep 12, 2025 | $0.00 | $0.00 | — | — | — | — | +0.2% |
| Apr 11, 2025 | −$0.01 | −$0.01 | −5.2% | $16.6K | — | — | −6.8% |
| Sep 26, 2024 | −$0.22 | −$0.33 | −49.8% | $16.6K | — | — | −2.6% |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | |||||||
| Apr 19, 2024 | |||||||
| Sep 15, 2023 | |||||||
| Apr 28, 2023 | |||||||
| Sep 14, 2022 | |||||||
| Apr 26, 2022 | |||||||
| Sep 17, 2021 | |||||||
| Apr 30, 2021 | |||||||
| Sep 10, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Apr 24, 2019 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Jun 30, 2013 | |||||||
| Dec 31, 2012 | |||||||
| Jun 30, 2012 | |||||||